1. Home
  2. APRE vs BLIN Comparison

APRE vs BLIN Comparison

Compare APRE & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
    SELLHOLDBUYas of 8 hours ago
  • BLIN
    SELLHOLDBUYas of 8 hours ago
  • Stock Information
  • Founded
  • APRE 2006
  • BLIN 2000
  • Country
  • APRE United States
  • BLIN United States
  • Employees
  • APRE N/A
  • BLIN N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • BLIN EDP Services
  • Sector
  • APRE Health Care
  • BLIN Technology
  • Exchange
  • APRE Nasdaq
  • BLIN Nasdaq
  • Market Cap
  • APRE 13.5M
  • BLIN 15.0M
  • IPO Year
  • APRE 2019
  • BLIN 2007
  • Fundamental
  • Price
  • APRE $1.70
  • BLIN $1.49
  • Analyst Decision
  • APRE Strong Buy
  • BLIN Strong Buy
  • Analyst Count
  • APRE 2
  • BLIN 1
  • Target Price
  • APRE $15.50
  • BLIN $4.62
  • AVG Volume (30 Days)
  • APRE 27.0K
  • BLIN 67.1K
  • Earning Date
  • APRE 05-13-2025
  • BLIN 05-13-2025
  • Dividend Yield
  • APRE N/A
  • BLIN N/A
  • EPS Growth
  • APRE N/A
  • BLIN N/A
  • EPS
  • APRE N/A
  • BLIN N/A
  • Revenue
  • APRE $1,502,581.00
  • BLIN $15,394,000.00
  • Revenue This Year
  • APRE N/A
  • BLIN $4.89
  • Revenue Next Year
  • APRE N/A
  • BLIN $10.49
  • P/E Ratio
  • APRE N/A
  • BLIN N/A
  • Revenue Growth
  • APRE 157.63
  • BLIN N/A
  • 52 Week Low
  • APRE $1.67
  • BLIN $0.76
  • 52 Week High
  • APRE $6.48
  • BLIN $2.80
  • Technical
  • Relative Strength Index (RSI)
  • APRE 23.11
  • BLIN 47.78
  • Support Level
  • APRE $2.17
  • BLIN $1.36
  • Resistance Level
  • APRE $2.30
  • BLIN $2.16
  • Average True Range (ATR)
  • APRE 0.16
  • BLIN 0.17
  • MACD
  • APRE -0.02
  • BLIN 0.03
  • Stochastic Oscillator
  • APRE 3.06
  • BLIN 16.25

Stock Price Comparison Chart: APRE vs BLIN

APRE
BLIN
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0102030405060708090100110120APRE VS BLIN

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use